Beyond PD-1/PD-L1, supplementary checkpoint molecules such as TIM-3 and LAG-3 are increasingly implicated in the immune landscape of NSCLC brain metastases. The gene discussed is HAVCR2; the disease is non-small cell lung carcinoma.